Sunday, October 20, 2019, 14:03

Treatment with pitolisant is associated with reductions in excessive daytime sleepiness (EDS) and cataplexy over a 1-year period in patients with narcolepsy, according to research presented at World Sleep 2019, held September 20 to 25, 2019, in Vancouver, Canada.

Click here to continue reading this article. 

No comments yet.
(*) Required fields
Copyright ©2019 Narcolepsy, No One Gets It ! , All Rights Reserved. 
Website hosted by
News stats: 20191722